AI TECHNOLOGY GROUP INC. - Form 8-K Filing

This Form 8-K filing details amendments to the Agreement and Plan of Merger between AI Technology Group Inc., AVM Biotechnology Inc., and Biomed 360 Solutions Corp. The amendments adjust "Investment Obligations" due to extended timelines from financial audit requirements. Key changes include confirmations of Tranche 1 ($1,000,000) and Tranche 2 ($1,125,000) loan amounts, with provisions for future Tranche 2 investments totaling $500,000 on specific dates through October 2026 and $375,000 in November 2026. These loans are convertible into Parent Shares at specified rates. The agreement also outlines a Tranche 3 requirement of at least $50,000,000 in gross proceeds by December 31, 2026, for an OTCQB listing and uplisting to a senior US stock exchange. Interest on Tranche 2 loans is set at 10% per annum. The Closing Date has been extended to December 31, 2026. All other terms of the original Merger Agreement remain in effect.